In acupuncture trials across the board, whether in the setting of cancer, chronic pain, or various other conditions, roughly one-third of patients are nonresponders, according to Dr. Mao.
His study was funded by the NIH’s National Center for Complementary and Alternative Medicine. He reported having no financial conflicts.